June 10, 2026 Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
June 10, 2026 Concentrix Schedules Release of Second Quarter 2026 Financial Results and Investor Conference Call